National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 7844-7845 [2017-01251]
Download as PDF
mstockstill on DSK3G9T082PROD with NOTICES
7844
Federal Register / Vol. 82, No. 13 / Monday, January 23, 2017 / Notices
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301) 435–
2306, kaushikbasun@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: BTSS and SAT.
Date: February 17, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative Applications: Child
Psychopathology.
Date: February 17, 2017.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Jane A DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
242: Bioengineering Research.
Date: February 17, 2017.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington, DC, 923
16th Street NW., Washington, DC 20006.
Contact Person: Yvonne Bennett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199,
MSC 7846, Bethesda, MD 20892, 301–379–
3793, bennetty@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Glycoscience Data Analysis Methods
Glycoscience Data Analysis Methods.
Date: February 17, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Raj K Krishnaraju, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
Bethesda, MD 20892, 301–435–1047,
kkrishna@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
19:02 Jan 19, 2017
Jkt 241001
Dated: January 13, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01250 Filed 1–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Drug
Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: February 15, 2017.
Closed: 9:00 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Open: 10:45 a.m. to 5:00 p.m.
Agenda: This portion of the meeting will
be open to the public for announcements and
reports of administrative, legislative, and
program developments in the drug abuse
field.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, NSC, Room 5274, MSC 9591,
Rockville, MD 20892, 301–443–6487,
sweiss@nida.nih.gov.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01254 Filed 1–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: February 10, 2017.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
E:\FR\FM\23JAN1.SGM
23JAN1
Federal Register / Vol. 82, No. 13 / Monday, January 23, 2017 / Notices
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Chelsea D. Boyd, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852–9834, 240–669–2081, chelsea.boyd@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01251 Filed 1–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2016–1050]
Towing Safety Advisory Committee;
Vacancies
Coast Guard, Department of
Homeland Security.
ACTION: Request for applications.
AGENCY:
The Coast Guard seeks
applications for membership on the
Towing Safety Advisory Committee.
This Committee advises the Secretary of
the Department of Homeland Security
on matters relating to shallow draft
inland and coastal waterway navigation
and towing safety.
DATES: Completed applications should
reach the Coast Guard on or before
March 9, 2017.
ADDRESSES: Applicants should send a
cover letter expressing interest in an
appointment to the Towing Safety
Advisory Committee that also identifies
which membership category the
applicant is applying under, along with
a resume detailing the applicant’s
experience via one of the following
methods:
• By Email: William.J.Abernathy@
uscg.mil
• By Fax: 202–372–8379 ATTN:
William Abernathy
• By Mail: William J. Abernathy,
Alternate Designated Federal Officer,
Commandant (CG–OES–2), U.S. Coast
Guard Stop 7509, 2703 Martin Luther
King Jr Ave SE., Washington, DC 20593–
7509
FOR FURTHER INFORMATION CONTACT:
William J. Abernathy, Alternate
Designated Federal Officer of the
Towing Safety Advisory Committee;
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:02 Jan 19, 2017
Jkt 241001
Telephone 202–372–1363; or Email at
William.J.Abernathy@uscg.mil.
SUPPLEMENTARY INFORMATION: The
Towing Safety Advisory Committee is a
federal advisory committee which
operates under the provisions of the
Federal Advisory Committee Act, (Title
5, United States Code, Appendix). It was
established under authority of the Act to
establish a Towing Safety Advisory
Committee in the Department of
Transportation, (Pub. L. 96–380), which
was recently amended by section 621 of
the Coast Guard Authorization Act of
2010, (Pub. L. 111–281). The Committee
advises the Secretary of Homeland
Security on matters relating to shallowdraft inland and coastal waterway
navigation and towing safety. This
advice also assists the Coast Guard in
formulating the position of the United
States regarding the towing industry in
advance of International Maritime
Organization meetings.
It is expected that the committee will
meet at least twice a year either in the
Washington, DC, area or in cities with
large towing centers of commerce and
populated by high concentrations of
towing industry and related businesses.
It may also meet for extraordinary
purposes. Its subcommittees may also
meet to consider specific tasks as
required. The Committee and its
subcommittees may conduct
intercessional telephonic meetings
when necessary, in response to specific
U.S. Coast Guard tasking.
Each Towing Safety Advisory
Committee member serves a term of
office of up to 3 years. Members may be
considered to serve an additional
consecutive term. All members serve
without compensation from the Federal
Government; however, upon request,
they may receive travel reimbursement
and per diem.
We will consider applications for the
following seven positions. The first
position listed is currently vacant, and
the rest will become vacant on
September 30, 2017:
1. One position representing the
holders of active licensed Masters of
towing vessels in offshore service;
2. Two positions representing the
Barge and Towing Industry (reflecting a
regional geographical balance);
3. One position representing port
districts, port authorities or terminal
operators;
4. One position representing holders
of active licensed Masters or Pilots of
towing vessels with experience on the
Western Rivers and the Gulf Intracoastal
Waterway;
5. One position representing active
Masters of ship-docking or harbor
towing vessels; and,
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
7845
6. One position drawn from the
general public.
To be eligible, applicants should have
particular expertise, knowledge, and
experience regarding shallow-draft
inland, coastal waterway navigation,
offshore navigation, and towing safety.
Registered lobbyists are not eligible to
serve on federal advisory committees in
an individual capacity. See ‘‘Revised
Guidance on Appointment of Lobbyists
to Federal Advisory Committees, Boards
and Commissions’’ (79 FR 47482,
August 13, 2014). The position we list
for a member from the general public
would be someone appointed in their
individual capacity and would be
designated as a Special Government
Employee as defined in 202(a), Title 18,
U.S.C. Registered lobbyists are lobbyists
as defined in 2 U.S.C. 1602 who are
required by 2 U.S.C. 1603 to register
with the Secretary of the Senate and the
Clerk of the House of Representatives.
If you are selected as a member drawn
from the general public, you will be
appointed and serve as a Special
Government Employee as defined in
section 202(a) of Title 18, United States
Code. As a candidate for appointment as
a Special Government Employee,
applicants are required to complete a
Confidential Financial Disclosure
Report (OGE Form 450). The Coast
Guard may not release the reports or the
information in them to the public except
under an order issued by a Federal court
or as otherwise provided under the
Privacy Act (5 U.S.C. 552a). Only the
Designated Coast Guard Ethics Official
or his or her designee may release a
Confidential Financial Disclosure
Report. Applicants can obtain this form
by going to the Web site of the Office of
Government Ethics (www.oge.gov), or by
contacting the individual listed above in
FOR FURTHER INFORMATION CONTACT.
Applications for a member drawn from
the general public that are not
accompanied by a completed OGE Form
450 will not be considered.
In an effort to maintain a geographic
balance of membership, we are
encouraging representatives from tug
and barge companies operating on the
Western Rivers to apply for
representation on the Committee.
The Department of Homeland
Security does not discriminate in
selection of Committee members on the
basis of race, color, religion, sex,
national origin, political affiliation,
sexual orientation, gender identity,
marital status, disabilities and genetic
information, age, membership in an
employee organization, or any other
non-merit factor. The Department of
Homeland Security strives to achieve a
E:\FR\FM\23JAN1.SGM
23JAN1
Agencies
[Federal Register Volume 82, Number 13 (Monday, January 23, 2017)]
[Notices]
[Pages 7844-7845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01251]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
Date: February 10, 2017.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
[[Page 7845]]
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Chelsea D. Boyd, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers
Lane, MSC-9823, Rockville, MD 20852-9834, 240-669-2081,
chelsea.boyd@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-01251 Filed 1-19-17; 8:45 am]
BILLING CODE 4140-01-P